Safety
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Vyepti Injection: Uses, Dosage, Side Effects, Precautions and Alternates
| Generic name | eptinezumab |
|---|---|
| Drug class | CGRP inhibitor (calcitonin gene-related peptide antagonist) |
| Forms | Concentrate for solution for infusion (100 mg and 300 mg vials) |
Quick overview
Vyepti Injection contains eptinezumab, a CGRP inhibitor given by IV infusion to help prevent migraine in adults. It is used for adults who have migraine at least 4 days per month, including both episodic and chronic migraine. Vyepti works by blocking calcitonin gene-related peptide (CGRP), a substance involved in triggering migraine attacks.
What is Vyepti Injection
Vyepti is a prescription medicine given by IV infusion to help prevent migraine in adults. It contains eptinezumab, an antibody that blocks a protein involved in migraine attacks.
Vyepti Injection uses
- Prevention of migraine in adults who have migraine at least 4 days per month
- Helps prevent both episodic migraine and chronic migraine
Benefits of Vyepti Injection
- Can reduce the number of days with migraine per month
- May improve quality of life
- Some people notice a preventive effect starting the day after the infusion
How Vyepti Injection works
Vyepti blocks a substance called calcitonin gene-related peptide (CGRP), which is involved in triggering migraine attacks. By blocking CGRP, the medicine helps stop the chain of events that leads to a migraine before it starts.
Vyepti Injection dosage
Vyepti is given as a drip (infusion) into a vein by a healthcare professional, usually taking about 30 minutes. It must not be given as a quick injection (bolus). You will be watched by a healthcare professional during and after the infusion for signs of an allergic reaction. Vyepti is not recommended for children or adolescents under 18 years because it has not been studied in this age group. If a dose is missed, your doctor will decide when the next dose should be given.
| Age group | Dose |
|---|---|
| Under 18 years | Safety and effectiveness have not been established |
| 18–64 years | 100 mg IV every 3 months; some patients may receive 300 mg IV every 3 months |
Available forms and strengths
- Concentrate for solution for infusion (100 mg and 300 mg vials)
Side effects of Vyepti Injection
Common
- Stuffy or runny nose (nasopharyngitis)
- Sore or scratchy throat
- Fatigue
- Hypersensitivity (allergic) reactions during or after infusion
Serious
- Serious allergic reactions, including anaphylaxis, with breathing difficulty, fast or weak pulse, sudden drop in blood pressure, swelling of lips or tongue, or severe itching/rash
- Severe constipation, sometimes requiring hospitalization
- High blood pressure or worsening of high blood pressure
- Raynaud's phenomenon (fingers or toes turning numb, cool, painful, or changing color from pale to blue to red)
Warnings and precautions
- Tell your doctor before treatment if you have heart or blood circulation disease, since people with these conditions were not well studied with this medicine.
- Serious allergic reactions, including anaphylaxis, can occur and may develop within minutes of the infusion.
- This medicine contains sorbitol, so people with hereditary fructose intolerance (a rare genetic condition) must not receive it unless strictly necessary.
- Severe constipation, sometimes needing hospital care, has happened after receiving this medicine.
- High blood pressure or worsening high blood pressure can occur after receiving this medicine.
- Raynaud's phenomenon, a circulation problem causing numb, cool, or painful fingers or toes that change color, can worsen or start after receiving this medicine.
- There is limited information on using Vyepti during pregnancy, so it is generally avoided unless your doctor decides it is clearly needed.
- It isn't known whether Vyepti passes into breast milk. Talk to your doctor about whether to breastfeed while using this medicine.
- No dose change is needed for people with kidney problems.
- No dose change is needed for people with liver problems.
- There are no known interactions between Vyepti and alcohol, though alcohol can trigger migraines in some people.
- Vyepti is not expected to affect your ability to drive or use machines.
Storage
- Store in a refrigerator (2°C - 8°C)
- Do not freeze or shake
- Keep the vial in the outer carton to protect from light
- If removed from the refrigerator, must be used within 7 days when stored in the original carton at room temperature (up to 25°C), or else discarded; do not put it back in the refrigerator once removed
- After dilution, the solution may be stored at room temperature (below 25°C) or in a refrigerator (2°C - 8°C), and must be used within 8 hours
- Do not use this medicine if the solution contains visible particles or is cloudy or discolored
- Do not throw away medicines via wastewater; ask your pharmacist how to dispose of medicines you no longer use
When to see a doctor
- Get emergency help right away if you have signs of a serious allergic reaction such as trouble breathing, a fast or weak pulse, a sudden drop in blood pressure causing dizziness, swelling of the lips or tongue, or severe itching or rash.
- Contact your healthcare provider if you have severe constipation or constipation with severe belly pain, vomiting, swelling of the belly, or bloating.
- Contact your healthcare provider if your blood pressure increases.
- Contact your healthcare provider if your fingers or toes become numb, cool, painful, or change color from pale to blue to red.
Alternatives
- Aimovig
- Ajovy
- Emgality
Watch the video
FAQs
What is Vyepti Injection used for?
Vyepti is used to prevent migraine in adults who have migraine at least 4 days per month, including both episodic and chronic migraine.
How does Vyepti Injection work?
Vyepti blocks calcitonin gene-related peptide (CGRP), a substance involved in triggering migraine attacks, helping to stop the chain of events that leads to a migraine before it starts.
How is Vyepti Injection given?
Vyepti is given as an IV infusion by a healthcare professional, usually over about 30 minutes. It must not be given as a quick injection, and you will be monitored during and after the infusion for allergic reactions.
What is the dosage of Vyepti Injection?
For adults aged 18-64, the dose is 100 mg IV every 3 months, though some patients may receive 300 mg IV every 3 months. It is not recommended for those under 18 years.
What are the serious side effects of Vyepti Injection?
Serious side effects include severe allergic reactions (anaphylaxis), severe constipation sometimes requiring hospitalization, high blood pressure, and Raynaud's phenomenon affecting fingers or toes.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Sources
Video
Related medicines
Injectafer Injection: Uses, Dosage, Side Effects, Precautions and Alternates
Iron products
Injectafer (ferric carboxymaltose) treats iron deficiency anemia and heart failure-related iron deficiency via IV. Learn uses, dosage, side effects, and
Gliclazide Tablet: Uses, Dosage, Side Effects, Precautions and Alternates
Sulfonylurea (hypoglycemic/antidiabetic agent)
Gliclazide Tablet is a sulfonylurea for type 2 diabetes that boosts insulin release. Learn about dosage, side effects, warnings, and precautions.